Cargando…
Corrigendum: Selective inhibition of EZH2 by ZLD1039 blocks H3K27methylation and leads to potent anti-tumor activity in breast cancer
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850860/ https://www.ncbi.nlm.nih.gov/pubmed/27128979 http://dx.doi.org/10.1038/srep24893 |
| _version_ | 1782429729795604480 |
|---|---|
| author | Song, Xuejiao Gao, Tiantao Wang, Ningyu Feng, Qiang You, Xinyu Ye, Tinghong Lei, Qian Zhu, Yongxia Xiong, Menghua Xia, Yong Yang, Fangfang Shi, Yaojie Wei, Yuquan Zhang, Lidan Yu, Luoting |
| author_facet | Song, Xuejiao Gao, Tiantao Wang, Ningyu Feng, Qiang You, Xinyu Ye, Tinghong Lei, Qian Zhu, Yongxia Xiong, Menghua Xia, Yong Yang, Fangfang Shi, Yaojie Wei, Yuquan Zhang, Lidan Yu, Luoting |
| author_sort | Song, Xuejiao |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4850860 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-48508602016-05-16 Corrigendum: Selective inhibition of EZH2 by ZLD1039 blocks H3K27methylation and leads to potent anti-tumor activity in breast cancer Song, Xuejiao Gao, Tiantao Wang, Ningyu Feng, Qiang You, Xinyu Ye, Tinghong Lei, Qian Zhu, Yongxia Xiong, Menghua Xia, Yong Yang, Fangfang Shi, Yaojie Wei, Yuquan Zhang, Lidan Yu, Luoting Sci Rep Corrigenda Nature Publishing Group 2016-04-29 /pmc/articles/PMC4850860/ /pubmed/27128979 http://dx.doi.org/10.1038/srep24893 Text en Copyright © 2016, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
| spellingShingle | Corrigenda Song, Xuejiao Gao, Tiantao Wang, Ningyu Feng, Qiang You, Xinyu Ye, Tinghong Lei, Qian Zhu, Yongxia Xiong, Menghua Xia, Yong Yang, Fangfang Shi, Yaojie Wei, Yuquan Zhang, Lidan Yu, Luoting Corrigendum: Selective inhibition of EZH2 by ZLD1039 blocks H3K27methylation and leads to potent anti-tumor activity in breast cancer |
| title | Corrigendum: Selective inhibition of EZH2 by ZLD1039 blocks H3K27methylation and leads to potent anti-tumor activity in breast cancer |
| title_full | Corrigendum: Selective inhibition of EZH2 by ZLD1039 blocks H3K27methylation and leads to potent anti-tumor activity in breast cancer |
| title_fullStr | Corrigendum: Selective inhibition of EZH2 by ZLD1039 blocks H3K27methylation and leads to potent anti-tumor activity in breast cancer |
| title_full_unstemmed | Corrigendum: Selective inhibition of EZH2 by ZLD1039 blocks H3K27methylation and leads to potent anti-tumor activity in breast cancer |
| title_short | Corrigendum: Selective inhibition of EZH2 by ZLD1039 blocks H3K27methylation and leads to potent anti-tumor activity in breast cancer |
| title_sort | corrigendum: selective inhibition of ezh2 by zld1039 blocks h3k27methylation and leads to potent anti-tumor activity in breast cancer |
| topic | Corrigenda |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850860/ https://www.ncbi.nlm.nih.gov/pubmed/27128979 http://dx.doi.org/10.1038/srep24893 |
| work_keys_str_mv | AT songxuejiao corrigendumselectiveinhibitionofezh2byzld1039blocksh3k27methylationandleadstopotentantitumoractivityinbreastcancer AT gaotiantao corrigendumselectiveinhibitionofezh2byzld1039blocksh3k27methylationandleadstopotentantitumoractivityinbreastcancer AT wangningyu corrigendumselectiveinhibitionofezh2byzld1039blocksh3k27methylationandleadstopotentantitumoractivityinbreastcancer AT fengqiang corrigendumselectiveinhibitionofezh2byzld1039blocksh3k27methylationandleadstopotentantitumoractivityinbreastcancer AT youxinyu corrigendumselectiveinhibitionofezh2byzld1039blocksh3k27methylationandleadstopotentantitumoractivityinbreastcancer AT yetinghong corrigendumselectiveinhibitionofezh2byzld1039blocksh3k27methylationandleadstopotentantitumoractivityinbreastcancer AT leiqian corrigendumselectiveinhibitionofezh2byzld1039blocksh3k27methylationandleadstopotentantitumoractivityinbreastcancer AT zhuyongxia corrigendumselectiveinhibitionofezh2byzld1039blocksh3k27methylationandleadstopotentantitumoractivityinbreastcancer AT xiongmenghua corrigendumselectiveinhibitionofezh2byzld1039blocksh3k27methylationandleadstopotentantitumoractivityinbreastcancer AT xiayong corrigendumselectiveinhibitionofezh2byzld1039blocksh3k27methylationandleadstopotentantitumoractivityinbreastcancer AT yangfangfang corrigendumselectiveinhibitionofezh2byzld1039blocksh3k27methylationandleadstopotentantitumoractivityinbreastcancer AT shiyaojie corrigendumselectiveinhibitionofezh2byzld1039blocksh3k27methylationandleadstopotentantitumoractivityinbreastcancer AT weiyuquan corrigendumselectiveinhibitionofezh2byzld1039blocksh3k27methylationandleadstopotentantitumoractivityinbreastcancer AT zhanglidan corrigendumselectiveinhibitionofezh2byzld1039blocksh3k27methylationandleadstopotentantitumoractivityinbreastcancer AT yuluoting corrigendumselectiveinhibitionofezh2byzld1039blocksh3k27methylationandleadstopotentantitumoractivityinbreastcancer |